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Abstract 
Cardiovascular disease (CVD) remains the leading cause of death among American adults accounting for approximately one-third of 
all deaths.  It has been shown, however, that the actual causes of death are related to lifestyle behaviors such as tobacco use, poor 
diet and physical activity and alcohol consumption.  A pharmacist-run employee health program, started in 2008, sought to lower 
CVD risk through the use of individualized lifestyle behavior programming, medication therapy management, and care coordination 
activities.  Following one year of participation in the program, employee participants were shown to significantly increase exercise 
quantity (p < 0.001), fruit and vegetable consumption (p < 0.001), and decrease self-reported stress level (p = 0.006).  The percentage 
of program participants simultaneously adherent to the recommended levels of exercise, combined fruit and vegetable intake and 
tobacco abstinence at one-year was 34.5% vs. 5.5% at baseline.  This compares with only 5.1% of the U.S. population adherent to the 
same three behaviors.  Pharmacists can positively impact healthy lifestyle behaviors when working in an employee health setting. 
 
 
Approximately 82,600,000 Americans (more than 1 in 3) 
currently have one or more types of cardiovascular disease 
(CVD) making it the number one cause of death in the United 
States and accounting for one-third of all deaths.
1
  Currently, 
CVD accounts for approximately 17% of the nation’s health 
care expenditures.
2
  The American Heart Association projects 
that by the year 2030, approximately 40.5% of the U.S. 
population will have some form of CVD.
2
  Between 2010 and 
2030 the direct and indirect health care costs associated with 
CVD are projected to increase by 200% and 61%, respectively.
2
 
 
It is known that the pre-clinical factors that lead to clinical CVD 
(i.e. atherosclerosis) begin early in life and that potentially 
modifiable risk factors related to healthy behaviors can 
decrease the risk for CVD.
3
  Primordial and primary prevention 
strategies related to a healthy lifestyle have been shown to be 
effective at decreasing CVD morbidity and mortality.
3
  
Adequate exercise, fruit and vegetable intake and tobacco 
cessation have all been shown to decrease CVD mortality by 
20% to 30%.
4-6
  Additionally, obtaining adequate sleep, 
consuming no more than moderate amounts of alcohol and 
managing stress may also have an effect on decreasing  
CVD morbidity and mortality.
7
  The American Heart  
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Association has recently published a policy statement showing 
that it is cost effective to deliver lifestyle related interventions 
for primordial and primary prevention.
3
 
 
Lifestyle medicine has been defined by the American College 
of Lifestyle Medicine as, “The use of lifestyle interventions in 
the treatment and management of disease.”
8
  Lifestyle 
interventions include proper nutrition, physical activity, 
tobacco cessation, stress management, sleep management, 
alcohol moderation, and others.  These strategies are 
recommended in nearly every major chronic disease practice 
guideline as first line treatment.
9
 The use of lifestyle medicine 
differs from conventional medicine in that it aims to prevent 
and treat the actual cause of disease, rather than treat the 
symptoms or complications. 
 
In 2004, Mokdad et al, from the Centers for Disease Control 
and Prevention (CDC), published a study comparing the 
expected leading causes of death in the U.S. to the actual 
causes of death.
10
  This study found that in 2000, the top three 
“causes of death” were heart disease, cancer and stroke.  
However, when looking at the “actual” reasons why Americans 
have these conditions, the study found the top reasons to be 
related to tobacco use, poor diet and physical inactivity and 
alcohol consumption.
10
  In 2005, a study was published using 
data from the 2000 Behavioral Risk Factor Surveillance System 
(BRFSS) that showed among American adults without coronary 
heart disease, only 5.1% were simultaneously adherent to the 
recommended levels of exercise and fruit and vegetable 
consumption in addition to abstinence from smoking.
11
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The purpose of this analysis is to report the effect that a 
pharmacist can have on the lifestyle medicine-related 
behaviors at baseline versus one-year for employees with 
chronic conditions who participate in a pharmacist-run 
employee health risk reduction program.  Prior to conducting 
the analysis, the project was submitted to the local 
Institutional Review Board for approval and oversight. The 
project was considered to be a continuous quality 
improvement measure of the employee risk reduction 
programs and therefore, oversight was deemed not necessary. 
 
Methods 
Risk Reduction Programs 
In 2008, a medium sized university in the Midwestern section 
of the United States initiated a pharmacist-run employee 
health Cardiovascular and Diabetes Risk Reduction Program.  
Employees were eligible to volunteer for the program if they 
had an existing diagnosis of hypertension, 
hypercholesterolemia diabetes mellitus, or a combination, 
thereof.  Employees could participate in the program for as 
long as they remained employed with the university and 
obtained their health care benefits from the employer.  The 
primary outcomes of the program were to (1) reduce the risk 
of experiencing a cardiovascular event within the next 10 
years; (2) improve the lifestyle habits of physical activity, 
healthy eating, stress management, sleeping, alcohol 
consumption, and tobacco use; (3) improve medication 
adherence; (4) improve quality of life; and (5) improve 
presenteeism (productivity) rates.  
 
Participants in the risk reduction programs attended one-on-
one appointments with the pharmacist at least one time per 
month.  Monthly visits consisted of medication therapy 
management activities, implementation and adherence to 
seven personalized lifestyle medicine programs (physical 
activity, healthy eating, stress management, restorative sleep, 
moderate alcohol consumption, tobacco abstinence/cessation, 
and weight control), and chronic disease care coordination 
practices.  Information regarding the care coordination 
practices within the program has been previously published.
12
 
 
In order to achieve the highest level of program adherence 
and success, each participant was provided with educational 
materials, a home blood pressure monitor, a pedometer, 
lifestyle behavior tracking tools, free access to the employers 
exercise facilities, monthly support group meetings, and 
access to a licensed mental health care provider.  Additionally, 
the employees with diabetes were provided with an initial 
consultation with a dietitian, six hours of American Diabetes 
Association approved education classes, and access to point-
of-care hemoglobin A1c analyses as needed.  Information 
regarding the interprofessional nature of the program and 
responsibilities of each care provider has been previously 
published.
13
 
 
Individual participant data was recorded in a database at 
baseline and annually thereafter.  Collected data consisted of 
cholesterol, blood pressure, and blood glucose lab values, 
body weight, lifestyle medicine behavior activities, medication 
refill records, health related quality of life (HRQOL) 
questionnaires, and presenteeism questionnaires.  With the 
permission from the participant, additional health information 
was also obtained from the annual health risk appraisal data 
collected by the employer and/or from the participant’s other 
health care professionals (ie. physician). 
 
Lifestyle Medicine Behaviors Analysis 
Participation in the risk reduction program was free to 
employees who met the program qualifications.  However, in 
order to retain the program benefits, participants were 
required to use a lifestyle medicine adherence tracking journal 
on a daily basis.
14
 Participants were required to bring their 
journal to each appointment with their pharmacist to improve 
accountability and monitor program adherence. 
The journal was organized in such a way that allowed for 
participants to write their weekly goals related to lifestyle 
medicine and disease management.  In addition, on a daily 
basis participants recorded the following information in their 
journal: 
- type, intensity and quantity of physical activity (minutes per 
day) 
-quantity of combined fruit and vegetables (servings per day) 
-quantity of sleep (hours per night) 
-quantity of alcoholic drinks (drinks per day) 
-overall daily stress rating using the following instructions and  
5 point scale: 
“Stress can change throughout the course of a day.  Think 
about your overall stress level today taking into consideration 
the high stress and low stress moments.  On a scale from 1 
(low stress) to 5 (high stress) how would you rate your overall 
stress level today?” 
1 Low Stress (feeling calm and in control) 
2  
3 Moderate Stress 
4  
5  High Stress (feeling frantic and out of control) 
Additionally, tobacco use was assessed and recorded on a 
monthly basis through conversations with the pharmacist.   
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On a monthly basis during the one-on-one appointments, the 
journal was reviewed by the pharmacist and an average of the 
previous 30 days of  lifestyle medicine activities listed above 
was recorded in the participant’s chart.  On an annual basis, 
the lifestyle medicine behaviors listed above were recorded in 
a database along with additional program data previously 
documented.  The lifestyle medicine-related data entered in 
the database was an average of that recorded for the 30 days 
prior to the participant’s anniversary appointment.  
Additionally, when an employee was initially enrolled in the 
program, they were interviewed by the pharmacist to obtain 
information about their participation in the lifestyle medicine 
behaviors listed above during the previous 30 days prior to 
program enrollment.  These data were also entered into the 
database as baseline lifestyle medicine-related behaviors. 
For the purposes of this analysis, the lifestyle medicine 
behavior data of exercise participation, combined fruit and 
vegetable consumption, tobacco use, alcohol consumption, 
sleep quantity, and overall stress rating recorded at baseline 
was then compared with data recorded at one year.  It should 
be noted that the quantity of exercise reported in this analysis 
includes “purposeful exercise” regardless of intensity.  
“Purposeful exercise” was defined for the participants as 
“physical activity that is sustained for at least 10 minutes, 
increases heart rate and breathing rate, and is performed for 
the purposes of exercise.”  Participants were also asked to 
record their “extra physical activity” obtained via activities of 
daily living such as parking further away in a parking lot, 
walking the dog, and taking the stairs.  This information was 
only recorded in the journal as either “yes” or “no” for each 
day and was not included in this analysis.  It should be further 
noted that fruit and vegetable consumption was recorded as 
combined daily servings and not as separate values. 
Participants 
The data reported in this analysis consists of the employees 
who participated in the Cardiovascular and Diabetes Risk 
Reduction Program and had matching lifestyle medicine data 
at both baseline and at one year.  The number of matching 
data points is different among the lifestyle medicine activities 
due to missing or unavailable data at the time of data 
collection.  The specific n for each activity ranges from 31 to 
54, and is clearly marked throughout the tables within this 
analysis. 
 
Statistical Analysis 
The statistical analysis for this project used the Wilcoxon 
signed-rank test as a non-parametric test to compare the 
median difference between the two time points.  A p value of 
<0.05 was considered statistically significant.  Descriptive 
analyses were also used to compare the number and 
percentage of employees participating in each of the lifestyle 
medicine activities. 
 
Results 
From August 2008 through May 2012 a total of 80 employees 
were enrolled in the risk reduction program.  Of these 
individuals, 63 (19 male / 44 female) completed at least one 
year of participation and had matching lifestyle medicine data 
collected at baseline and at one year..  The average age of the 
participants at enrollment was 52.2 years with 40 having an 
existing diagnosis of hypertension, 46 having hyperlipidemia 
and 23 having diabetes mellitus type 2.  The lifestyle medicine 
data was analyzed for the group as a whole as well as 
separately for those with and without diabetes.   
 
Table 1 compares baseline data for exercise, combined fruit 
and vegetable consumption, sleep quantity and stress rating 
to that recorded after participating for one year in the risk 
reduction program.  The one-year results showed that overall, 
the group demonstrated a significant increase in the amount 
of exercise (p < 0.001) and fruit and vegetable consumption (p 
< 0.001), as well as a decrease in self-reported stress (p = 
0.006) compared with baseline.  No statistically or clinically 
significant difference was observed with regards to the 
quantity of sleep participants received at baseline versus one 
year. 
 
The diabetes subgroup demonstrated improvements in all four 
lifestyle medicine activities listed in Table 1, but showed 
statistical improvement with only the combined fruit and 
vegetable consumption activity (p < 0.012).  A relative increase 
of 90% was demonstrated with the amount of exercise 
performed each week in this group but was not statistically 
significant (p = 0.062).  The number of individuals included in 
this analysis was relatively small (n = 11-16) which may have 
underpowered the analysis to show statistically significant 
changes. 
 
The non-diabetes subgroup results were similar to that of the 
overall group showing statistical changes in the exercise (p < 
0.001), combined fruit and vegetable (p < 0.001), and stress 
rating (p = 0.002) activities, but not with regard to sleep 
quantity (p = 0.138).  The number of participants was greater 
in this subgroup compared with the diabetes subgroup, which 
suggests that overall, the group data was largely positive due 
to the outcomes of the non-diabetes subgroup. 
Among the 63 individuals who completed at least one year of 
the risk reduction program, only three employees smoked at 
baseline (2 of 3 in diabetes subgroup).  After one year in the 
program one of the three employees who smoked successfully 
quit.  There were not enough individuals who smoked tobacco 
to include this activity in the statistical analysis.   
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Likewise, there were not enough employees who drank 
alcohol to conduct a statistical analysis.  However, analyzing 
the data descriptively showed that only one employee 
consumed greater than moderate amounts of alcohol and did 
so at both baseline and at one-year.  The average number of 
drinks consumed by this female employee was two per day 
(one drink/day is considered moderate intake for women).
7
   
 
Table 2 demonstrates the percentage of employees who 
achieved the recommended amounts of physical activity and 
combined fruit and vegetable consumption at baseline versus 
one-year.  The overall group, as well as each subgroup, 
showed an increase in the percentage of risk reduction 
participants who were achieving the recommended amounts.  
In addition, the percentage of employees achieving the 
recommended amounts of physical activity and combined fruit 
and vegetable consumption at one-year exceeded that 
reported for the general adult U.S. population.  This was also 
true when looking at each subgroup separately.  It should be 
noted that the general U.S. population statistics included 
adults with and without chronic conditions, and that our 
analysis included only individuals with one or more chronic 
conditions. 
 
The recommended amount of sleep for adults ranges from 7 
to 9 hours per night.
7
  When looking at the percentage of 
employees who reported getting less than 7 hours per night, 
the data showed improvements for the overall group as well 
as for each subgroup.  At baseline, 40% (16/40) of the overall 
group was getting less than 7 hours of sleep per night 
compared with 30% (12/40) at one-year.  The diabetes 
subgroup reported 44.4% (8/18) at baseline and 38.9% (7/18) 
at one-year.  The non-diabetes group reported 36.4% (8/22) at 
baseline and 22.7% (5/22) at one-year.  This compares to 
national data where 35.3% of U.S. adults report getting less 
than 7 hours of sleep per night.
15
  Not enough employees used 
tobacco or alcohol to perform a descriptive analysis as done 
with physical activity, fruit and vegetable intake and sleep 
quantity.  Additionally, the stress rating tool used in the risk 
reduction programs does not allow for this type of analysis. 
 
Figure 1 also shows the percentage of employee participants 
who are achieving the recommended amounts of multiple 
lifestyle medicine activities at the same time.  This analysis 
looked at each employee’s ability to achieve the 
recommended amounts of physical activity, combined fruit 
and vegetable consumption along with tobacco abstinence 
simultaneously.  The results show that the percentage of the 
overall group increased from 5.5% to 34.5% with a similar 
increase demonstrated in each subgroup.  Of note is the 
comparability of the individuals included in this analysis at 
baseline with that reported for the general U.S. population, 
5.5% vs. 5.1%, respectively.
11
 
 
Discussion 
Our analysis shows that a pharmacist-run risk reduction 
program conducted in an employee health setting for 
individuals with chronic conditions can significantly improve 
lifestyle medicine-related cardiovascular risk factors after one 
year of participation.  It has been shown that the most 
prevalent “actual causes of death” in Americans are related to 
tobacco use, poor nutrition and physical inactivity.
10
  Previous 
research has shown that tobacco cessation, adequate fruit and 
vegetable consumption, and adequate amounts of exercise 
can each lower CVD risk by 20% to 30%.
4-6
  Our data show- 
that after one year of participation, over one-third of 
participant employees were simultaneously achieving the 
recommended levels of all three of these lifestyle medicine 
activities, compared with only 5% of the general U.S. 
population.  Lifestyle medicine aims to prevent and treat the 
actual cause of disease, and our data demonstrate that the 
risk reduction programs may be having a positive impact on 
this endeavor. 
 
In addition to the quantitative lifestyle medicine data 
presented in this analysis, we conducted a focus group session 
with eight participants to obtain additional qualitative 
information.  When participants were asked about lifestyle 
medicine activity improvements related to the programs, 
responses overwhelmingly favored the one-on-one meetings 
with a pharmacist as the most important aspect of the 
program that helped them reach their goals as related to 
lifestyle medicine.  Participants articulated that the 
pharmacists were accessible, held them accountable to their 
individual program and provided necessary motivation and 
frequent practical advice.   
 
It may be untraditional to think of a pharmacist using lifestyle 
medicine to prevent and treat diseases.  Most all health care 
providers, including pharmacists, work with patients who have 
one or more chronic conditions.  Interestingly, the treatment 
guidelines for the management of the most common chronic 
conditions, such as hypertension, dyslipidemia, coronary heart 
disease, diabetes, obesity and many others list lifestyle 
medicine-related strategies as first-line therapy.
9
  An 
argument can be made that in order for pharmacists to best 
help patients manage their chronic conditions, they should be 
counseling about both drug therapy and lifestyle medicine 
strategies.  In fact, lifestyle medicine is an area that cross-cuts 
almost all healthcare professions and therefore, nearly all 
healthcare professionals could be talking with their patients 
about lifestyle medicine. 
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It may also be untraditional to think of a pharmacist working in 
a setting that does not involve the dispensing of medications.  
The employee health setting may offer pharmacists an 
excellent professional opportunity to use their skills in the 
absence of a medication dispensing role.  The data presented 
in this manuscript come from a pharmacist-run employee 
health program that does not involve the dispensing of 
medications.  The role of the pharmacist in this program is to 
emphasize medication therapy management, lifestyle 
medicine and care coordination activities to improve the 
health and well-being of an employee population.  In order to 
conduct a program such as this, a pharmacist may need to 
receive additional training in the areas of lifestyle medicine 
and care coordination.  This training could be obtained 
formally in school, as well as through additional training after 
graduation.  Other opportunities for pharmacists in the 
employee health setting may include educating employees on 
medical self-care topics, working with the employer on their 
drug formulary, and providing immunizations to employees. 
 
More research and analysis is required in order to gain 
additional understanding of how a pharmacist can affect 
lifestyle medicine-related cardiovascular risk factors.  
Pharmacists working in a community pharmacy setting may 
also be able to incorate lifestyle medicine programs to 
improve the health and well-being of their patients. Not only 
do pharmacists have frequent exposure to individuals with 
chronic conditions on a daily basis, but they are also easily 
accessible healthcare providers, making them a valuable 
resource for the community regarding lifestyle medicine 
activities.  Pharmacists may be able to effectively provide 
counseling for both medication use and lifestyle modifications 
when dispensing medication in a community pharmacy 
setting. 
 
Our analysis did contain a number of limitations that should 
be mentioned.  The number of participants was small, and the 
overall analysis time period was short.  One of the main goals 
of the risk reduction program is to decrease the long-term risk 
for experiencing a cardiovascular event.  Although the data 
presented in this analysis are encouraging, additional long-
term data on more employees are needed to show lasting 
program success.  Additionally, from its inception, this 
program was designed to be a self-sustaining employee health 
program and not a research study.  As a result, the lifestyle 
medicine data collected is self-reported, and to some extent, 
from recall.  The stress rating scale that is used in the program 
and reported in this manuscript is one that was designed 
specifically for the program. This tool does not have statistical 
validity but does, however, offer a great deal of clinical use 
and significance.  Overall nutrition success is difficult to 
quantify, and this analysis only used fruit and vegetable intake 
as an assessment of healthy eating.  Each individual 
participant’s nutrition assessments are gauged on many 
factors, but for simplicity in data collection and reporting, fruit 
and vegetable intake was used for this report.  Also, many 
aspects related to sleep can affect an individual’s health.  Our 
analysis only reports the quantity of sleep obtained, and not 
the quality of sleep an individual is receiving.   
 
Lastly, the comparison made between the individuals in this 
analysis and those included in the 2009 BRFSS survey 
regarding those who achieved all three healthy behaviors 
simultaneously should consider the fact that those in the 
BRFSS self-reported no chronic conditions.  The individuals in 
our analysis included only individuals with at least one chronic 
medical condition, and therefore a direct comparison cannot 
be made.  Also, the criteria the BRFSS questionnaire used for 
achieving adequate exercise was >150 minutes/week of 
moderate or >60 minutes/week of vigorous exercise, and our 
program used >150 minutes/week of moderate or >75 
minutes/week of vigorous exercise.  Our criteria were more 
stringent making this comparison more conservative.  The 
percentage of individuals in our program achieving all three 
healthy activities may have been greater if we had used >60 
minutes/week of vigorous activity as in the 2009 BRFSS. 
 
Conclusion 
Cardiovascular disease remains the leading cause of death 
among Americans.  However, these deaths are related to 
lifestyle behaviors, such as tobacco use, poor nutrition and 
physical inactivity.  Our data show that a pharmacist can have 
a positive impact on the lifestyle medicine-related 
cardiovascular risk factors that can lead to CVD.  These 
positive changes were observed when looking at individual 
lifestyle medicine activities, as well as the ability to 
successfully participate in multiple activities at the same time.  
Pharmacists may be able to positively impact employee health 
by performing services that are unrelated to medication 
dispensing.  More programs and research related to 
pharmacists working in this setting are needed to reinforce 
the positive outcomes presented in this manuscript.  The 
pharmacist’s role in promoting lifestyle medicine activities has 
great potential in many different pharmacy practice settings. 
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Table 1.  Change in the quantity of lifestyle medicine activities at baseline versus one-year. 
 
Lifestyle Medicine 
Activity 
Exercise, 
minutes/week 
 Combined Fruit & 
Vegetable, 
servings/day 
Sleep, hours/night Stress, rating* 
Baseline vs One-Year  
(actual / relative difference, p value) 
Overall** 68.2 vs 174.8 
(+106 min/wk / 
+156%, p < 0.001) 
3.1 vs 4.3 
(+1.2 serv/day / 
39%, p < 0.001) 
7.0 vs 7.1 
(+0.1 hrs/night / 
+1.4%, p = 0.109) 
3.2 vs 2.5 
(-0.7 / -22% 
p = 0.006) 
Diabetes† 44.0 vs 83.4 
(+39.4 min/wk / 
+90%, p = 0.062) 
3.2 vs 4.1 
(+0.9 serv/day / 
+28%, p = 0.012) 
6.8 vs 7.1 
(+0.3 hrs/night / 
+4.4%, p = 0.564) 
3.1 vs 2.8 
( -0.3/ -10% 
p = 0.565) 
Non-Diabetes‡ 75.2 vs 215.4 
(+140.2 min/wk / 
+186%, p < 0.001) 
2.8 vs 4.4 
(+1.6 serv/day / 
+57%, p < 0.001) 
7.0 vs 7.1 
(+0.1 hrs/night / 
+1.4%, (p = 0.138) 
3.3 vs 2.4 
(-0.9 / -27% 
p = 0.002) 
 
*Stress: Overall daily stress was self-rated on a 1-5 scale as follows: 1=Low Stress (feeling calm and in control), 2, 3=Moderate Stress, 
4, 5 High Stress (feeling frantic and out of control) 
**n for exercise, fruit and vegetable, sleep, stress is 52, 55, 41, and 31, respectively 
† n for exercise, fruit and vegetable, sleep, stress is 16, 19, 18, 11, respectively 
‡ n for exercise, fruit and vegetable, sleep, stress is 36, 36, 23, 20, respectively 
 
 
 
 
 
Table 2.  Percentage of employees at goal for physical activity and fruit/vegetable consumption. 
 
Lifestyle Medicine 
Activity*  
Baseline, % One-Year, % National Data, % 
Physical Activity 
Overall 24.1 (13/54) 53.7 (29/54) 50.6** 
Diabetes 11.1 (2/18) 38.9 (7/18) No data 
Non-Diabetes 30.6 (11/36) 61.1 (22/36) No data 
Combined Fruit & Vegetable Consumption 
Overall 16.7 (9/54) 37.0 (20/54) 23.5** 
Diabetes 15.8 (3/19) 36.8 (7/19) No data 
Non-Diabetes 17.1 (6/35) 37.1 (13/35) No data 
 
*Physical Activity Goal:  >150 min/wk of moderate or >75 min/wk of vigorous intensity or combination; Combined Fruit & Vegetable 
Goal: >5 servings/day  
**Reference #15 
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Figure 1.  Percentage of employee participants vs. percentage of the general U.S. population achieving  
recommended amounts of exercise, fruit and vegetable consumption and tobacco abstinence simultaneously.
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